Leon E. Chen
Director/Board Member at Eikon Therapeutics, Inc.
Profile
Leon E.
Chen is the founder of KAI Pharmaceuticals, Inc. (founded in 2002).
He currently holds positions as a Director at Eikon Therapeutics, Inc., Remix Therapeutics, Inc., Velia, Inc., Logic Bio, and Partner at The Column Group LLC (since 2019).
Previously, he held positions as a Director at Crescendo Bioscience LLC, Sutro Biopharma, Inc., Genocea Biosciences, Inc., Nurix Therapeutics, Inc., LogicBio Therapeutics, Inc., Pionyr Immunotherapeutics, Inc., Principal at Venrock Associates, Partner at Skyline Management LLC, Venture Partner at OrbiMed Advisors Private Equity, and Chief Executive & Financial Officer at ESCAPE Bio, Inc. Dr. Chen obtained a doctorate degree from Stanford University in 2001, an undergraduate degree from the University of California, Berkeley in 1997, and an MBA from Stanford Graduate School of Business in 2009.
Leon E. Chen active positions
| Companies | Position | Start |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Private Equity Investor | 2019-09-30 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director/Board Member | - |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA. | Director/Board Member | - |
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023. | Director/Board Member | - |
Former positions of Leon E. Chen
| Companies | Position | End |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Director/Board Member | 2022-11-15 |
| NURIX THERAPEUTICS, INC. | Director/Board Member | 2021-05-27 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Private Equity Investor | 2019-09-29 |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA. | Chief Executive Officer | 2018-08-22 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 2013-06-29 |
Training of Leon E. Chen
| University of California, Berkeley | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Finance |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Finance |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA. | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA. | Commercial Services |
Velia, Inc.
Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023. | Technology Services |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Leon E. Chen
